Mitomycin C
ROCHE/10107409001 - crystalline powder, 98%, pkg of 2 mg
Synonym: Mitomycin C
CAS Number: 50-07-7
Empirical Formula (Hill Notation): C15H18N4O5
Molecular Weight: 334.33
Linear Formula: C15H18N4O5
Product Type: Chemical
antibiotic activity spectrum | Gram-negative bacteria |
Gram-positive bacteria | |
assay | 98% |
form | crystalline powder |
InChI | 1S/C15H18N4O5/c1-5-9(16)1 |
InChI key | NWIBSHFKIJFRCO-WUDYKRTCSA |
manufacturer/tradename | Roche |
mode of action | DNA synthesis | interferes |
mol wt | 334.3 |
packaging | pkg of 2 mg |
Quality Level | 100 |
storage temp. | 2-8°C |
Application: | Mitomycin C has been used: • to cease mitosis • in phosphate buffer saline (PBS) for inactivation and plating mouse embryonic fibroblasts (MEFs) • as mutagen in mutagenicity assay |
Application: | Mitomycin C is used as an inhibitor for studies of cell-free protein biosynthesis. It also inhibits DNA synthesis. It has been used as a genotoxic agent for tumor cells. |
Biochem/physiol Actions: | Mitomycin C (MMC) acts as a prototype for drugs with bioreductive alkylation. It is mainly found to be active under anaerobic conditions. MMC exhibits a vast clinical antitumor spectrum effectively in gastric, pancreatic and breast cancer. |
General description: | Mitomycin C is an antitumor antibiotic. |
Other Notes: | For life science research only. Not for use in diagnostic procedures. |
Symbol | GHS06,GHS08 |
Signal word | Danger |
Hazard statements | H300 - H351 |
Precautionary statements | P201 - P264 - P280 - P301 + P310 + P330 - P308 + P313 - P501 |
RIDADR | UN 2811 6.1 / PGII |
WGK Germany | WGK 3 |
Flash Point(F) | does not flash |
Flash Point(C) | does not flash |
Purity | 98% |
Storage Temp. | 2-8°C |
UNSPSC | 12352207 |